BrukervsUnitedHealth

BRKR and UNH stock compared: price, dividend, valuation and results, from SEC filings.

BRKR

Bruker Corporation

$63.26

Value $9.6B

+3.10%
BRKR's page

UNH

UnitedHealth Group Incorporated

$349.91

Value $318B

-10.21%
UNH's page

Bruker (BRKR) has a market value of $9.6B and UnitedHealth (UNH) $318B. Over the last year, with dividends, BRKR moved +52.1% and UNH +12.1%. Dividend yield: BRKR 0.32%, UNH 2.59%.

At a glance

The main figures of both. A bar only shows which number is larger, not which is better.

  • Market value

    BRKR$9.6B

    UNH$318B

    UNH is 33 times BRKR

  • Revenue, 12 months

    BRKR$3.5B

    UNH$450B

    UNH is 128 times BRKR

  • Net income, 12 months

    BRKR-$123M

    UNH$15.9B

  • Operating margin

    BRKR-2.0%

    UNH5.3%

    7.3 points apart

  • ROIC

    BRKR-1.3%

    UNH11.3%

    12.6 points apart

  • P/E

    BRKR–

    UNH20.0

  • Dividend yield

    BRKR0.3%

    UNH2.6%

    2.3 points apart

  • 5-year return

    BRKR-24.6%

    UNH-14.7%

    9.9 points apart

A fainter bar means a negative number. The 5-year return includes dividends.

The price over time

Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.

BRKR-24.6%

UNH-14.7%

5010015020222023202420252026
Returns by period
PeriodBRKRWith dividendsUNHWith dividends
1 year since November 17, 2025+52.1%Price +51.4%+12.1%Price +9.2%
3 years since November 17, 2023+4.5%+1.5% a yearPrice +3.2%-30.5%-11.4% a yearPrice -34.8%
5 years since November 17, 2021-24.6%-5.5% a yearPrice -25.9%-14.7%-3.1% a yearPrice -22.1%
10 years since November 21, 2016+189.3%+11.2% a yearPrice +178.2%+174.7%+10.6% a yearPrice +132.6%

Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.

Every figure

As on each company's page. A description, not a recommendation: no one figure says which is better.

BRKRBrukerUNHUnitedHealth

Valuation

BRKRUNH
Valuation
Price$63.26$349.91
Market value$9.6B$318B
Enterprise value (EV)$11.2B$363B
P/E–20.0
P/E, 5-year median40.425.0
P/B4.23.1
EV/EBIT–15.2
Free cash flow yield2.5%7.2%

Results and growth

BRKRUNH
Results and growth
Revenue, 12 months$3.5B$450B
Net income, 12 months-$123M$15.9B
Free cash flow, 12 months$245M$22.8B
Earnings per share, 12 months-$1.10$17.52
Revenue growth, year on year2.1%11.8%
Revenue growth a year, past+11.6%over 5 years+11.7%over 5 years
EPS growth a year, past–-3.8%over 5 years

Margins and returns on capital

BRKRUNH
Margins and returns on capital
Gross margin47.7%88.3%
Operating margin-2.0%5.3%
Net margin-3.5%3.5%
ROIC-1.3%11.3%
ROE-5.1%15.5%

Balance sheet

BRKRUNH
Balance sheet
Cash$120M$28.5B
Total debt$1.7B$74.3B
Net debt / EBITDA10.61.6
Interest cover-1.2×6.2×

Dividends and buybacks

BRKRUNH
Dividends and buybacks
Dividend yield0.3%2.6%
Dividend per share, 12 months$0.20$9.06
Dividend growth a year, past-1.4%over 5 years+12.6%over 5 years
Buyback yield0.1%1.8%
Shareholder yield0.4%4.3%

Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.

Questions: BRKR or UNH

Didn't find what you were looking for?

Ask us
Which is bigger, Bruker or UnitedHealth?

By market value, UnitedHealth ($318B) is about 33.0 times Bruker ($9.6B), at today's prices.

How did BRKR and UNH stock do over the last 10 years?

Since November 21, 2016, BRKR's price moved +178.2% and UNH's +132.6%. With dividends: BRKR +189.3% (+11.2% a year), UNH +174.7% (+10.6% a year). Past returns do not predict future ones.

Which pays the higher dividend, BRKR or UNH?

The dividend yield at today's price is 0.32% for Bruker and 2.59% for UnitedHealth. Over the last twelve months they paid $0.20 and $9.06 per share.

Which has the higher profit margins, Bruker or UnitedHealth?

Over the last twelve months, the net margin was -3.5% for Bruker and 3.5% for UnitedHealth, and the operating margin -2.0% and 5.3%. Revenue was $3.5B and $450B.

Which is the better investment, Bruker or UnitedHealth?

The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.

Other comparisons

With each of the two, and with the largest in its sector.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

Descriptive data from SEC filings and market prices.